Biopharm Services

News from BPS


Feb 2012: New Technology Grant

1 FEB 2011: Biopharm Services has been awarded a UK Technology Strategy Board grant to develop our software bioprocess database application to support rapid bioprocess development and technology transfer to manufacturing. Extending the functionality of the BioSolve platform to recipe management and facility fit.


New Newsletter published

New Newsletter published October 2011. Gives details of the exciting changes happening with the BioSolve Suite.


Annual Bioprocess Simulation prize

Biopharm Service's Annual Bioprocess Simulation prize was awarded in November 2011 to a team of undergraduate students at UCL's Department of Biochemical Engineering for their work on "Application of BioSolve computer simulation tool for investigating the process economics of antibody production". The BioSolve modelling tool was used to evaluate the economics of a process to produce an IgG antibody for treating arthritis and to understand impact of scale-up to and for process optimisation. This demonstrates the value of BioSolve to help students within the teaching programmes at UCL to understand the impact of process and technology choices.
Download the UCL BioSolve poster


Past President of the IChemE joins the Biopharm Team

Bioprocess specialist Stephen Vranch joins Biopharm Services. Since 1968 Stephen has held senior positions in Project and Process Engineering, Fermentation and Process Development and in Production of Diagnostics and Biological Therapeutic Pharmaceuticals, including licensed bulk product. Stephen was a former President of the IChemE. As our lead consultant, Stephen specialises on all aspects of CGMP regulatory compliance.


BioSolve

BioSolve used to generate data for GE lifecycle assessment of the entire monocloncal antibody production process: a comparison of multi-use and single-use processes. Upcoming webinar

Adoption of BioSolve Process in UCL Biochemical Engineering Courses

BioPharm Services is pleased to announce the adoption of BioSolve Process by the Biochemical Engineering Department of University College London (UCL). The cost modelling software has been used for both undergraduate and postgraduate courses including the MBI® programme (Modular Training for the Bioprocess Industries). MORE »

Delivering operational excellence to biologics

Latest news

1 FEB 2011: Biopharm Services has been awarded a UK technology strategy board grant to develop our software bioprocess database application to support rapid bioprocess development and technology transfer to manufacturing. Extending the functionality of the BioSolve platform to recipe management and facility fit.

Biopharm Service's Annual Bioprocess Simulation prize was awarded in November 2011 to a team of undergraduate students at UCL's Department of Biochemical Engineering for their work on "Application of BioSolve computer simulation tool for investigating the process economics of antibody production. MORE

Featured article in the October 2011 edition of Bioprocess International by Andrew Sinclair and Miriam Monge, 'Cost benefits of Hybrid disposable systems'

New Newsletter published October 2011. Gives details of the exciting changes happening with the BioSolve Suite.

Past President of the IChemE joins the Biopharm Team. Bioprocess specialist Stephen Vranch joins Biopharm Services. MORE

BioSolve
BioSolve used to generate data for GE lifecycle assessment of the entire monocloncal antibody production process: a comparison of multi-use and single-use processes. Webinar presentation

Where to meet us

Bioprocess International European conference 18th - 19th April, Prague
'Use of bioprocess analysis modelling tools to develop more robust, cost effective downstream processes, a Medimmune case study'
Dr Richard Turner, Associate Director Downstream processing, Medimmune UK
Ms Miriam Monge, VP Marketing & bioprocess applications, Biopharm Services, UK


IBC's 9th Single-Use Applications for Biopharm Manufacturing,
4th – 6th June 2012, San Francisco

'Scalable single-use bioreactors for implementation in Sanofi Pasteur's commercial vaccine manufacturing, a supply chain risk assessment'
Jean-Marc Guillaume, Head of R&D and process development Sanofi Pasteur, France
Miriam Monge, Vice President Biopharm Services Ltd

  • Disposable supply chain risk assessment methodology
  • Case study: Sanofi Pasteur supply chain risk assessment for disposable bioreactors

'Economics of Disposable Systems Implications of Scaling up for Commercial Manufacture - Scale Up vs. Scale Out'

Andrew Sinclair, President Biopharm Services Ltd

The talk will review optimal strategies for using disposables cell culture systems in hybrid facilities (a mixture of stainless and disposable technologies). In particular we will examine the costs of these facilities, their scalability and where they have advantages over a conventional reference stainless steel facility and where they do not. Specifically the questions that are addressed are:

  1. What is the best configuration for the hybrid facility? Multiple 1000L bioreactors or multiple 2000L bioreactors?
  2. What harvest configuration should be used in terms of pooling bioreactor harvests?
  3. How does the best hybrid option compare to stainless steel with changing facility utilisation?

Where to contact us

+44 (0)1494 793243    
info@biopharmservices.com

Contact details and location maps